tirzepatide novo nordisk Eli Lilly launches weight-loss drug Mounjaro in India, beats to major market FDA Grants Tirzepatide a New
Description
During clinical trials, researchers observed that patients were losing significant weight, and semaglutide was later approved for weight management in 2021

Common Side Effects and How to Manage Them While semaglutide is generally well-tolerated, some patients may experience side effects, especially when first starting the treatment

High-potency and long-aging neuromuscular depot forms carry the greatest risk

In animal experiments, administering bimagrumab along with a GLP-1 agonist preserved muscle mass while increasing the amount of fat lost

It acts on the anterior pituitary to trigger endogenous growth hormone pulses, which then stimulate IGF-1 production in the liver
While Mounjaro can be highly effective for weight loss, like all medications, it may cause some side effects